High Point Advisor Group LLC Edwards Lifesciences Corp Transaction History

High Point Advisor Group LLC

$1.67 Billion
Q3 2024

A detailed history of High Point Advisor Group LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, High Point Advisor Group LLC holds 11,403 shares of EW stock, worth $853,058. This represents 0.04% of its overall portfolio holdings.

Number of Shares

11,403

Previous 12,524 8.95%

Holding current value

$853,058

Previous $1.16 Million 34.95%

% of portfolio

0.04%

Previous 0.07%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$59.7 - $93.78 $66,923 - $105,127	-1,121 Reduced 8.95%	11,403 $752,000
Q2 2024 Aug 08, 2024	BUY	$84.3 - $94.31 $758 - $848	9 Added 0.07%	12,524 $1.16 Million
Q1 2024 May 14, 2024	SELL	$72.54 - $95.56 $797 - $1,051	-11 Reduced 0.09%	12,515 $1.2 Million
Q4 2023 Mar 26, 2024	SELL	$61.71 - $77.76 $616,791 - $777,211	-9,995 Reduced 44.38%	12,526 $955,000
Q2 2022 Aug 15, 2022	BUY	$86.5 - $128.27 $986,792 - $1.46 Million	11,408 Added 102.65%	22,521 $2.21 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $19,861 - $23,690	-193 Reduced 1.71%	11,113 $1.26 Million
Q2 2021 Jul 29, 2021	BUY	$83.84 - $104.76 $56,508 - $70,608	674 Added 6.34%	11,306 $1.17 Million
Q1 2021 Apr 12, 2021	BUY	$78.68 - $90.67 $130,923 - $150,874	1,664 Added 18.55%	10,632 $914,000
Q4 2020 Feb 10, 2021	BUY	$71.69 - $91.23 $50,398 - $64,134	703 Added 8.51%	8,968 $769,000
Q3 2020 Nov 06, 2020	SELL	$67.19 - $87.44 $32,587 - $42,408	-485 Reduced 5.54%	8,265 $641,000
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $338,910 - $453,235	5,890 Added 205.94%	8,750 $604,000
Q1 2020 May 01, 2020	BUY	$52.41 - $81.0 $116,402 - $179,901	2,221 Added 347.57%	2,860 $639,000
Q1 2020 Apr 27, 2020	SELL	$52.41 - $81.0 $242,815 - $375,273	-4,633 Reduced 87.88%	639 $2.86 Million
Q4 2019 Feb 13, 2020	SELL	$71.7 - $82.09 $7,385 - $8,455	-103 Reduced 1.92%	5,272 $1.28 Million
Q3 2019 Nov 12, 2019	BUY	$61.55 - $75.43 $153,197 - $187,745	2,489 Added 86.24%	5,375 $1.26 Million
Q2 2019 Aug 15, 2019	SELL	$55.74 - $64.41 $1,337 - $1,545	-24 Reduced 0.82%	2,886 $559,000
Q1 2019 May 08, 2019	SELL	$47.89 - $64.05 $143 - $192	-3 Reduced 0.1%	2,910 $518,000
Q4 2018 Feb 20, 2019	BUY	$46.41 - $56.94 $4,084 - $5,010	88 Added 3.12%	2,913 $515,000
Q3 2018 Oct 24, 2018	SELL	$45.7 - $58.03 $3,701 - $4,700	-81 Reduced 2.79%	2,825 $422,000
Q2 2018 Aug 20, 2018	BUY	$42.45 - $51.3 $382 - $461	9 Added 0.31%	2,906 $405,000
Q1 2018 Jun 11, 2018	BUY	$37.19 - $47.45 $29,677 - $37,865	798 Added 38.02%	2,897 $414,000
Q4 2017 Feb 15, 2018	SELL	$33.79 - $39.39 $10,204 - $11,895	-302 Reduced 12.58%	2,099 $267,000
Q3 2017 Nov 06, 2017	BUY	$36.29 - $38.83 $87,132 - $93,230	2,401	2,401 $243,000

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Point Advisor Group LLC with notifications on news.

Account

High Point Advisor Group LLC Edwards Lifesciences Corp Transaction History